AppLovin Corporation (APP) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.69%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 4.13%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.69% | Research and development expense / revenue. Period ending 2026-06-30. $320.08M ÷ $6.83B × 100 ≈ 4.69% |
| Stock-based compensation / revenue · 12 months | 4.13% | Share-based compensation / revenue. Period ending 2026-06-30. $282.38M ÷ $6.83B × 100 ≈ 4.13% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 320.08M USD | Research and Development Expense |
| Revenue | 6.83B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 282.38M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 5.29B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $320.08M | $6.83B | $282.38M | $5.29B | (m) | 4.69% | 4.13% | (m) | (m) |
| 2026-03-31 | $264.21M | $6.16B | $232.51M | $4.75B | (m) | 4.29% | 3.77% | (m) | (m) |
| 2025-12-31 | $226.51M | $5.48B | $210.42M | $4.15B | (m) | 4.13% | 3.84% | (m) | (m) |
| 2025-09-30 | $514.13M | $6.31B | $224.00M | $3.47B | (m) | 8.15% | 3.55% | (m) | (m) |
| 2025-06-30 | $551.06M | $5.74B | $272.42M | $2.92B | (m) | 9.60% | 4.75% | (m) | (m) |
| 2025-03-31 | $606.28M | $5.14B | $335.39M | $2.20B | (m) | 11.81% | 6.53% | (m) | (m) |
| 2024-12-31 | $638.69M | $4.71B | $369.37M | $1.87B | (m) | 13.56% | 7.84% | (m) | (m) |
| 2024-09-30 | $620.03M | $4.29B | $363.58M | $1.53B | (m) | 14.45% | 8.48% | (m) | (m) |
| 2024-06-30 | $629.33M | $3.96B | $392.87M | $1.19B | (m) | 15.91% | 9.93% | (m) | (m) |
| 2024-03-31 | $602.86M | $3.63B | $375.39M | $926.72M | (m) | 16.63% | 10.35% | (m) | (m) |
| 2023-12-31 | $592.39M | $3.28B | $363.11M | $648.21M | (m) | 18.04% | 11.06% | (m) | (m) |
| 2023-09-30 | $559.75M | $3.03B | $322.73M | $356.27M | (m) | 18.46% | 10.64% | (m) | (m) |
| 2023-06-30 | $522.52M | $2.88B | $254.03M | $219.22M | (m) | 18.14% | 8.82% | (m) | (m) |
| 2023-03-31 | $526.21M | $2.91B | $229.94M | $141.24M | (m) | 18.10% | 7.91% | (m) | (m) |
| 2022-12-31 | $507.61M | $2.82B | $191.61M | $-47.79M | (m) | 18.02% | 6.80% | (m) | (m) |
| 2022-09-30 | $508.96M | $2.91B | $185.29M | $33.16M | (m) | 17.50% | 6.37% | (m) | (m) |
| 2022-06-30 | $495.42M | $2.92B | $177.87M | $28.94M | (m) | 16.95% | 6.09% | (m) | (m) |
| 2022-03-31 | $431.78M | $2.81B | $147.86M | $10.56M | (m) | 15.34% | 5.25% | (m) | (m) |
| 2021-12-31 | $366.40M | $2.79B | $133.18M | $150.02M | (m) | 13.12% | 4.77% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $180.65M | $1.45B | $62.39M | $-62.04M | (m) | 12.45% | 4.30% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $44.97M | $994.10M | $10.22M | $194.37M | (m) | 4.52% | 1.03% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.